Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-03-03
1989-03-28
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544291, A61K 31505, C07D40514
Patent
active
048164550
ABSTRACT:
A new anhydrous crystalline form of prazosine hydrochloride characterized by the following bands in the infra-red spectrum in potassium bromide is described:
REFERENCES:
patent: 4026894 (1977-05-01), Winn et al.
patent: 4092315 (1978-05-01), Bianco
patent: 4251532 (1981-02-01), Bateman
Lehmann et al., "Chemical Abstracts", vol. 95, 1981, Col. 95:62250b.
Lehmann et al., "Chemical Abstracts", vol. 101, 1984, Col. 101:90971y.
Lehmann et al., "Chemical Abstracts", vol. 101, 1984, Col. 101:230571v.
Lehmann et al., "Chemical Abstracts", vol. 102; 1985, Col. 102:62270w.
Lindholm, "Chemical Abstracts", vol. 103, 1985, Col. 103:11460w.
Lehmann et al., "Chemical Abstracts", vol. 106, 1987, Col. 106:33113z.
Ahrens Kurt H.
Grafe Ingomar
Schickaneder Helmut
Heumann Pharma GmbH & Co.
Hollrah Glennon H.
Turnipseed James H.
LandOfFree
Crystalline, anhydrous sigma-form of 2-(4-(2-furoyl)-(2-piperazi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline, anhydrous sigma-form of 2-(4-(2-furoyl)-(2-piperazi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline, anhydrous sigma-form of 2-(4-(2-furoyl)-(2-piperazi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659371